DataM resources that are widely useful for your reference. We have curated special links for you to browse through

The generalized myasthenia gravis treatment landscape is evolving with the FDA approval of KLYGEFA and continued development of complement inhibitors, FcRn antagonists, B-cell therapies and CAR-T programs. Explore approved drugs, clinical-stage assets, pharmaceutical companies, competitive positioning and the global gMG treatment market outlook through 2035.
November 17, 2026

SolidUltra has secured $3.36 million in funding to develop modular 800 VDC solid-state transformers (SSTs) for AI data centers, targeting high-density computing power distribution. The France-based company aims to commercialize medium-voltage solid-state transformer technology by 2028, with projected 98.5% conversion efficiency and reduced equipment footprint.
November 13, 2026

GE Vernova has announced a $34.5 million investment to expand transformer manufacturing capacity at its Shreveport, Louisiana, facility, with full production capacity expected in 2028. The project includes manufacturing equipment upgrades, process improvements and factory infrastructure enhancements, supporting industrial and renewable energy applications.
November 13, 2026